Once-daily metoprolol in primary hypertension

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Clinical Hypertension

Background:

• Primary hypertension is a common condition requiring effective management.
• Selective beta-1 adrenoceptor blockers are a class of antihypertensive medications.
• Metoprolol's efficacy and duration of action in hypertension warrant further investigation.

Purpose of the Study:

• To evaluate the antihypertensive effect of once-daily metoprolol in patients with primary hypertension.
• To assess the dose-dependent efficacy of metoprolol (150 mg vs. 300 mg).
• To explore correlations between metoprolol's effects and plasma renin activity, electrolytes, and aldosterone levels.

Main Methods:

• A randomized, placebo-controlled study involving 32 patients with primary hypertension.
• Patients received either 150 mg or 300 mg of metoprolol once daily for 8 weeks after a 4-week placebo period.
• Blood and urine samples were collected to measure metoprolol plasma levels, plasma renin activity (PRA), electrolytes, and urinary aldosterone.

Main Results:

• Metoprolol demonstrated antihypertensive effects lasting up to 26 hours post-dose.
• Response rates were 40% for 150 mg and 71% for 300 mg metoprolol.
• A correlation between baseline PRA and antihypertensive effect was observed with the 300 mg dose.

Conclusions:

• Once-daily metoprolol is effective in managing primary hypertension.
• A 300 mg dose of metoprolol shows a higher response rate compared to 150 mg.
• The antihypertensive effect of metoprolol may be influenced by baseline plasma renin activity, particularly at higher doses.